| Esophageal carcinoma: towards targeted therapies A Fatehi Hassanabad, R Chehade, D Breadner, J Raphael Cellular Oncology 43, 195-209, 2020 | 128 | 2020 |
| Familial papillary thyroid carcinoma: a retrospective analysis TJ McDonald, AA Driedger, BM Garcia, SHM Van Uum, I Rachinsky, ... Journal of oncology 2011 (1), 948786, 2011 | 69 | 2011 |
| Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma T Zhang, B Sun, C Zhong, K Xu, Z Wang, P Hofman, T Nagano, A Legras, ... Translational lung cancer research 10 (4), 1857, 2021 | 61 | 2021 |
| Electrochemistry of ferrocene-functionalized phosphonium ionic liquids JEF Weaver, D Breadner, F Deng, B Ramjee, PJ Ragogna, RW Murray The Journal of Physical Chemistry C 115 (39), 19379-19385, 2011 | 47 | 2011 |
| Discovery of novel integrin ligands from combinatorial libraries using a multiplex “beads on a bead” approach CF Cho, GA Amadei, D Breadner, LG Luyt, JD Lewis Nano letters 12 (11), 5957-5965, 2012 | 39 | 2012 |
| Design, synthesis and in vitro characterization of Glucagon-Like Peptide-1 derivatives for pancreatic beta cell imaging by SPECT BB Azad, VA Rota, D Breadner, S Dhanvantari, LG Luyt Bioorganic & medicinal chemistry 18 (3), 1265-1272, 2010 | 26 | 2010 |
| Imaging of homeostatic, neoplastic, and injured tissues by HA-based probes M Veiseh, D Breadner, J Ma, N Akentieva, RC Savani, R Harrison, ... Biomacromolecules 13 (1), 12-22, 2012 | 20 | 2012 |
| Efficacy and safety of ALK inhibitors in ALK-rearranged non-small cell lung cancer: a systematic review and meta-analysis D Breadner, P Blanchette, S Shanmuganathan, RG Boldt, J Raphael Lung Cancer 144, 57-63, 2020 | 19 | 2020 |
| Phase I/II trial of dose-reduced capecitabine in elderly patients with advanced colorectal cancer MD Vincent, D Breadner, MC Cripps, DJ Jonker, P Klimo, JJ Biagi, W Lam, ... Current Oncology 24 (4), e261, 2017 | 19 | 2017 |
| Phase II trial of capecitabine plus erlotinib versus capecitabine alone in patients with advanced colorectal cancer V Mark D, B Daniel, S Denis, K Ian G, S Michael, K Walter, K Peter, ... Future Oncology 13 (9), 777-786, 2017 | 15 | 2017 |
| Investigation of isomer formation upon coordination of bifunctional histidine analogues with 99m Tc/Re (CO) 3 EJ Simpson, JL Hickey, D Breadner, LG Luyt Dalton Transactions 41 (10), 2950-2958, 2012 | 13 | 2012 |
| Exploitation of treatment induced tumor lysis to enhance the sensitivity of ctDNA analysis: A first-in-human pilot study DA Breadner, MD Vincent, R Correa, M Black, A Warner, M Sanatani, ... Lung Cancer 165, 145-151, 2022 | 9 | 2022 |
| Skin deep: a fascinating case report of immunotherapy-triggered, treatment-refractory autoimmune lichen planus and keratoacanthoma BTB Preti, A Pencz, JJM Cowger, MD Vincent, D Breadner Case Reports in Oncology 14 (2), 1189-1193, 2021 | 9 | 2021 |
| The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: a multicentered retrospective analysis D Breadner, JM Loree, WY Cheung, M Gipson, S Lakkunarajah, ... BMC cancer 22 (1), 1119, 2022 | 8 | 2022 |
| The influence of adjuvant chemotherapy dose intensity on five-year outcomes in resected colon cancer: A single centre retrospective analysis S Lakkunarajah, DA Breadner, H Zhang, E Yamanaka, A Warner, S Welch Current Oncology 28 (5), 4031-4041, 2021 | 8 | 2021 |
| CircRHOT1 restricts gastric cancer cell ferroptosis by epigenetically regulating GPX4 H Wang, DA Breadner, K Deng, J Niu Journal of gastrointestinal oncology 14 (4), 1715, 2023 | 6 | 2023 |
| The efficacy of anlotinib as third-line treatment for non-small cell lung cancer by EGFR mutation status: a subgroup analysis of the ALTER0303 randomized phase 3 study Y Zhao, Q Wang, L Zhang, J Shi, Z Wang, Y Cheng, J He, Y Shi, W Chen, ... Translational Lung Cancer Research 11 (5), 776, 2022 | 6 | 2022 |
| Molecular profiling of solid tumors by next-generation sequencing: an experience from a clinical laboratory P Bhai, J Turowec, S Santos, J Kerkhof, LA Pickard, A Foroutan, ... Frontiers in Oncology 13, 1208244, 2023 | 5 | 2023 |
| Raltitrexed as a substitute for capecitabine in metastatic gastric cancer: a case report and literature review I Ladak, B Preti, B Dias, DA Breadner Annals of Translational Medicine 10 (23), 2022 | 5 | 2022 |
| Health related quality of life in older or frail patients with advanced colorectal cancer treated with dose reduced capecitabine D Breadner, MD Vincent, D Jonker, C Cripps, P Klimo, J Biagi, W Lam, ... Journal of geriatric oncology 9 (6), 659-664, 2018 | 5 | 2018 |
